The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.

Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.

Prioritising US health, Trump has already frozen the supply of HIV and malaria medication aid to endemic countries.

Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...

Acellera and Psivant have announced a strategic research partnership aimed at developing computational drug discovery ...

The potential secretary for Health and Human Services has been forced to defend his previous anti-vaccine stances at his ...

Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO, succeeding Jessica ...

AstraZeneca and Daiichi Sankyo ’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from ...

The FDA has granted RMAT designation to Beacon Therapeutics’ gene therapy, laru-zova, for treating X-linked retinitis pigmentosa (XLRP).

The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.

The new indication makes Ozempic the first glucagon-like peptide-1 receptor agonist (GLP-1RA) available for people with T2D ...

Sonnet BioTherapeutics has received a patent from the European Patent Office (EPO) for its fully human albumin binding (FHAB) technology.